Dec 06, 09:11
Dec 06, 09:08
Only SellersOnly Sellers in Sterling Bio on NSE
Only SellersOnly Sellers in Sterling Bio on BSE
52 Week HighSterling Bio has hit a 52wk high of Rs 10.45 on BSE
52 Week HighSterling Bio has hit a 52wk high of Rs 9.67 on BSE
52 Week HighSterling Bio has hit a 52wk high of Rs 8.45 on NSE
AnnouncementsSterling Biotech: Outcome of bond holders meeting
AnnouncementsSterling Biotech: Outcome of board meeting
|Company Name||Last Price||%
|Dr Reddys Labs||2421.95||0.36||2545.00||1764.00||41,197.31|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Sterling Bio is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 250.19 crore.The company has reported a standalone sales of Rs 162.46 crore and a Net Loss of Rs 99.38 crore for the quarter ended Sep 2013.
The company management includes Nitin J Sandesara - Chairman & Managing Director, Chetan J Sandesara - Joint Managing Director, Rajbhushan Dixit - Director, Vilas D Joshi - Director, Priyadarshan B Mehta - Director, Narendrabhai B Patel - Director.
It is listed on the BSE with a BSE Code of 512299 and the NSE with an NSE Code of STERLINBIO.
Its Registered office is at 43, Atlanta Building, Nariman Point, Mumbai,Maharashtra - 400021.